Literature DB >> 11739219

Prescriptions for antiulcer drugs in Australia: volume, trends, and costs.

J I Westbrook1, A E Duggan, J H McIntosh.   

Abstract

Mesh:

Substances:

Year:  2001        PMID: 11739219      PMCID: PMC60672          DOI: 10.1136/bmj.323.7325.1338

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  2 in total

1.  Factors associated with consulting medical or non-medical practitioners for dyspepsia: an australian population-based study.

Authors:  J I Westbrook; J McIntosh; N J Talley
Journal:  Aliment Pharmacol Ther       Date:  2000-12       Impact factor: 8.171

2.  Compliance with restrictions on the subsidized use of proton pump inhibitors in Australia.

Authors:  P McManus; J Marley; D J Birkett; J Lindner
Journal:  Br J Clin Pharmacol       Date:  1998-10       Impact factor: 4.335

  2 in total
  7 in total

1.  Restricted access for PPIs not a panacea.

Authors:  Anne E Duggan; Johanna Westbrook
Journal:  CMAJ       Date:  2002-11-12       Impact factor: 8.262

2.  Reducing dyspepsia costs in the community.

Authors:  A Duggan; J Westbrook
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

3.  A 9 year prospective cohort study of endoscoped patients with upper gastrointestinal symptoms.

Authors:  Johanna I Westbrook; Anne E Duggan; John M Duggan; Mary T Westbrook
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

4.  Use of gastroprotective agents in recommended doses in hospitalized patients receiving NSAIDs: a drug utilization study.

Authors:  Viktorija Erdeljic; Igor Francetic; Viola Macolic Sarinic; Marinko Bilusic; Ksenija Makar Ausperger; Mirjana Huic; Iveta Mercep
Journal:  Pharm World Sci       Date:  2006-11-17

Review 5.  The role of protein digestibility and antacids on food allergy outcomes.

Authors:  Eva Untersmayr; Erika Jensen-Jarolim
Journal:  J Allergy Clin Immunol       Date:  2008-06       Impact factor: 10.793

6.  Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies.

Authors:  Sandra Dial; Khalid Alrasadi; Chantal Manoukian; Allen Huang; Dick Menzies
Journal:  CMAJ       Date:  2004-07-06       Impact factor: 8.262

7.  Estimating medical costs of gastroenterological diseases.

Authors:  Li-Fang Chou
Journal:  World J Gastroenterol       Date:  2004-01-15       Impact factor: 5.742

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.